Newly Published DPIResearch Report-Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 Research Report

DPI Research published a new report on Coronavirus (Covid19) Vaccines Pipeline Assessment 2020. The research offers an extensive analysis of key players active in the Covid19 Vaccines Pipeline Assessment. Detailed analysis on operating business segments, product pipeline, business performance, and key strategic developments is offered in the research.

Download Report Sample:

“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market. The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention. It also evaluates the vaccines developed against MERS-CoV and SARS-CoV. The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research. The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase. The report investigates detailed insights about countries, territories, or areas with reported laboratory-confirmed Coronavirus (COVID-19) cases and deaths. Key trends in terms of collaboration and partnership deals are analyzed with details. 

The report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market. The key players are evaluated on the various parameters such as business overview, promising vaccine in clinical development, and recent development.

Report Scope:

  • Extensive coverage of the Coronavirus (COVID-19) vaccine under development
  • Detailed Insights of the Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and Prevention
  • Provides Comprehensive Insights on the Funding of the Coronavirus (COVID-19) Vaccine Research
  • Thoroughly Evaluates Vaccines Developed Against MERS-CoV and SARS-CoV
  • Reviews Most Recent Clinical Trials of the Coronavirus Vaccines
  • Scrutinizes Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths
  • Provides Key Trends with Respect to Collaboration and Partnership Deals
  • An Insightful Analysis of the Key Vaccine Developers Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

Enquire for customization in Report @:

Key Vaccine Developers Covered in the Report

  • University of Oxford
  • Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline
  • Heat Biologics Inc./University of Miami
  • Inovio Pharmaceuticals Inc
  • Janssen Pharmaceutical
  • Sanofi Pasteur/GlaxoSmithKline (GSK)
  • Moderna/NIAID
  • Novavax
  • Sanofi Pasteur/Translate Bio Inc.
  • Vaxart Inc.
  • Altimmune
  • Medicago
  • BioNTech/Pfizer/Fosun Pharma
  • GeoVax/BravoVax
  • Arcturus Therapeutics/Duke-NUS
  • CanSino Biological Inc/Beijing Institute of Biotechnology
  • Takis Biotech/Applied DNA Sciences/Evvivax
  • Cobra Biologics/Karolinska Institute
  • Zydus Cadila
  • Codagenix/Serum Institute of India
  • Greffex
  • ExpreS2ion Biotechnologies ApS
  • Vaxil Bio Therapeutics
  • Flow Pharma Inc
  • AJ Vaccines
  • Generex Biotechnology/EpiVax
  • Immunomic Therapeutics/EpiVax/PharmaJet
  • iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute
  • VIDO-InterVac/University of Saskatchewan/International Vaccine Institute
  • Tonix Pharmaceuticals/Southern Research
  • IAVI/Batavia Biosciences
  • Curevac
  • Imophoron Ltd/University of Bristol
  • BioNet Asia
  • Sinovac/Dynavax
  • University of Pittsburgh

For More Information@

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web:
Direct Line: +91-766-764-8693

Spread the love

2 Replies to “Newly Published DPIResearch Report-Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 Research Report”

Leave a Reply

Your email address will not be published. Required fields are marked *